Clinical Trials Using Anti-CD40L Fc-Fusion Protein BMS-986004
Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-CD40L Fc-Fusion Protein BMS-986004. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
BMS-986004, Sirolimus, and Tacrolimus in Preventing Graft Versus Host Disease after Donor Stem Cell Transplant in Patients with Hematologic Cancer or Blood Disorder
This phase I / II trial studies the side effects, best dose and how well BMS-986004 works when given together with sirolimus and tacrolimus in preventing graft versus host disease after donor stem cell transplant in patients with hematologic cancer or blood disorder. Immunosuppressive therapy, such as BMS-986004, sirolimus, and tacrolimus, are used to decrease the body’s immune response and may help reduce the incidence of graft versus host disease.
Location: Moffitt Cancer Center, Tampa, Florida